SLC22A17 as a Cell Death-Linked Regulator of Tight Junctions in Cerebral Ischemia.

Using a combination of cell culture, human stroke samples, and mouse models, our data suggest that SLC22A17 may play a role in the control of BBB function after cerebral ischemia. These findings may offer a novel mechanism and target for ameliorating BBB injury and edema after stroke.